Medical - Drugs
Industry Rank
More Info
The Zacks Industry Rank assigns a rating to each of the 248 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 248), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (248 out of 248) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
The Zacks Industry Rank assigns a rating to each of the 248 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 248), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (248 out of 248) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
-8.14%
YTD Return More Info
Year to Date (YTD) Return shows the median percentage price change for the respective equally-weighted Industry since the beginning of the year.
Updated Oct 26
Sector: Medical
Performance
| Total Return % | IVV(iShares-SP500) | |
|---|---|---|
| 1 Month | 0.19 | 3.25 |
| 3 Months | 1.23 | 6.20 |
| YTD | -8.14 | 6.70 |
| 1 Year | -0.29 | 14.52 |
| 3 Years | -16.96 | 39.46 |
| 5 Years | -16.37 | 76.88 |
Medical - Drugs Performance
Key Metrics for
Industry Earnings
| Industry | IVV(iShares-SP500) | |
|---|---|---|
| PE (F1) | 18.57 | 21.07 |
| PEG (Ratio) | 2.31 | 2.69 |
| Proj EPS Growth | 19.73% | -2.24% |
| Hist EPS Growth | 7.74% | 10.10% |
| Net Margin | -113.38% | 10.35% |
| Hist Sales Growth | 8.60% | 6.03% |
| Hist Dividend Growth | 0.00% | 1.45% |
Financial Ratios
| Industry | IVV(iShares-SP500) | |
|---|---|---|
| Beta | 1.18 | 1.06 |
| ROE | -58.30 | 14.88 |
| ROA | -38.78 | 5.62 |
| ROI | -55.72 | 9.01 |
| Debt-to-Equity | 0.00 | 0.70 |
| Current Ratio | 3.88 | 1.37 |
| Cash Flow ($/share) | -10.03 | 1,991.00 |
| Price to Book | 3.39 | 1.45 |
| Price To Sales | 7.03 | 2.56 |
| Dividend Yield | 0.00% | 1.66% |